Evidence map›Paper›PMID 28387712›Full record

ReviewProteomes2017

A Comprehensive Guide for Performing Sample Preparation and Top-Down Protein Analysis.

Matthew P Padula, Iain J Berry, Matthew B O Rourke, Benjamin B A Raymond, Jerran Santos, Steven P Djordjevic

Abstract readReview
In one paragraph

Review in Proteomes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Study of βScientific reports · 2023
    Article
  7. Review
  8. Review
  9. Proteomics in Inherited Metabolic Disorders.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthew P PadulaProteomics Core Facility, University of Technology Sydney PO Box 123, Broadway 2007, Australia. matthew.padula@uts.edu.au.
Iain J BerryProteomics Core Facility, University of Technology Sydney PO Box 123, Broadway 2007, Australia. iain.j.berry@student.uts.edu.au.
Matthew B O RourkeProteomics Core Facility, University of Technology Sydney PO Box 123, Broadway 2007, Australia. matthew.orourke@sydney.edu.au.
Benjamin B A RaymondProteomics Core Facility, University of Technology Sydney PO Box 123, Broadway 2007, Australia. benjamin.raymond@uts.edu.au.
Jerran SantosProteomics Core Facility, University of Technology Sydney PO Box 123, Broadway 2007, Australia. jerran.santos@uts.edu.au.
Steven P DjordjevicProteomics Core Facility, University of Technology Sydney PO Box 123, Broadway 2007, Australia. steven.djordjevic@uts.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methodologies for the global analysis of proteins in a sample, or proteome analysis, have been available since 1975 when Patrick O'Farrell published the first paper describing two-dimensional gel electrophoresis (2D-PAGE). This technique allowed the resolution of single protein isoforms, or proteoforms, into single 'spots' in a polyacrylamide gel, allowing the quantitation of changes in a proteoform's abundance to ascertain changes in an organism's phenotype when conditions change. In pursuit of the comprehensive profiling of the proteome, significant advances in technology have made the identification and quantitation of intact proteoforms from complex mixtures of proteins more routine, allowing analysis of the proteome from the 'Top-Down'. However, the number of proteoforms detected by Top-Down methodologies such as 2D-PAGE or mass spectrometry has not significantly increased since O'Farrell's paper when compared to Bottom-Up, peptide-centric techniques. This article explores and explains the numerous methodologies and technologies available to analyse the proteome from the Top-Down with a strong emphasis on the necessity to analyse intact proteoforms as a better indicator of changes in biology and phenotype. We arrive at the conclusion that the complete and comprehensive profiling of an organism's proteome is still, at present, beyond our reach but the continuing evolution of protein fractionation techniques and mass spectrometry brings comprehensive Top-Down proteome profiling closer.

Indexed as

Bottom-upChromatographyElectrophoresisIsoelectric focusingMass spectrometryProteoformProteomicsTop-Down

Identifiers

PMID28387712
PMCPMC5489772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.